NVS News and Press, Novartis AG From 04/27/24

2024-04-27 15:39:17 ET More on Amgen, Cullinan Oncology, etc. Amgen: I Prefer To Chase Value And Dividends Amgen: The Giant With An Impressive Pipeline Move Over Eli Lilly: Amgen Could Be The Next Obesity Wonder Stock Cullinan Therapeutics expands into autoim...

2024-04-27 07:00:00 ET Summary Attempting to time the market is not a successful strategy. Long-term investing has consistently outperformed market timing. Today, the S&P is fairly valued, but blue-chip bargains are plentiful if you know where to look. These 16 dividend ar...

2024-04-26 15:56:40 ET Summary Shares of Deciphera Pharmaceuticals, Inc. have rallied 40% since October after positive trial data for vimseltinib in the treatment of TGCT. Vimseltinib is expected to make significant progress in the TGCT indication, as the only approved therapy is ...

2024-04-25 17:49:16 ET Summary The Annual Meeting of the American Society of Clinical Oncology is a major event for clinicians and researchers in the field of oncology. The plenary session will feature presentations on topics such as esophageal cancer, melanoma, and lung cancer. ...

2024-04-23 18:25:09 ET Scooting past analyst estimates for its latest quarter gave Novartis (NYSE: NVS) a lift on Tuesday. Investors like what they heard about the global healthcare company's inaugural earnings release for 2024, and rewarded Novartis with a more than 2% lift in its ...

2024-04-23 15:00:03 ET Wan Nurhayati from CFRA issued a price target of $108.00 for NVS on 2024-04-23 13:11:00. The adjusted price target was set to $108.00. At the time of the announcement, NVS was trading at $97.27. NVS currently trades -10.58% versus its 52 week high ...

2024-04-23 14:08:57 ET More on Novartis Novartis AG (NVS) Q1 2024 Earnings Call Transcript Novartis: Strong Start To The Year With Beat-And-Raise First Quarter Results Novartis AG 2024 Q1 - Results - Earnings Call Presentation Biggest stock movers today: SPOT...

2024-04-23 13:32:13 ET More on Sanofi Sanofi: My Top Pick In Big Pharma Sanofi (SNY) Barclays 26th Annual Global Healthcare Conference (Transcript) Sanofi (SNY) Leerink Partners Global Biopharma Conference (Transcript) Sanofi succeeds in late-stage trial for ...

2024-04-23 11:55:26 ET Novartis AG (NVS) Q1 2024 Earnings Conference Call April 23, 2024, 08:00 AM ET Company Participants Sloan Simpson - Head of Investor Relations Vas Narasimhan - Chief Executive Officer Harry Kirsch - Chief Financial Officer Conference ...

2024-04-23 11:15:11 ET Image source: The Motley Fool. Novartis Ag (NYSE: NVS) Q1 2024 Earnings Call Apr 23, 2024 , 8:00 a.m. ET Operator Continue reading For further details see: Novartis Ag (NVS) Q1 2024 Earnings Call Transcript